Aurora Cannabis expands into Portugal with the acquisition of 51% stake in Gaia Pharma

Aurora Cannabis Inc. has announced that it has agreed to acquire a 51% ownership interest in Gaia Pharm Lda to establish a local facility to produce medical cannabis and derivative products. The company will be renamed "Aurora Portugal Lda". On February 21, 2019, Gaia Pharm Lda. received approval of its application to construct an EU GMP compliant cannabis cultivation facility from INFARMED, a division of the Portuguese Health Ministry, which is responsible for the evaluation, authorization, regulation and control of human medicines as well as health products for the protection of public health.

"Construction of the new facility will be conducted in phases, with the first phase expected to be completed in the third calendar quarter of 2020. Upon completion, the first phase of the facility is expected to have a production capacity of approximately 2,000 kg per annum, growing to 4,000 kg per annum upon completion of the second phase.", the team with the company explains. 

For more information:
Aurora
P.O. Box 209
Cremona, AB. T0M0R0
1-844-928-7672
auroramj.com


Publication date :


Print   

Receive the daily newsletter in your email for free | Click here


Other news in this sector:


© HortiDaily.com 2019

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber